Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V

Scharl Anton J.; Beckmann Matthias W.

首页> 外文期刊>Geburtshilfe und Frauenheilkunde >Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V

【24h】

Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V

机译：柏林，25.04.2019第277第277届妇科肿瘤工作组委员会委员会的陈述（前）e。 V.在德国妇科和妇产科社会中。 V.关于Palbociclib（乳腺癌） - 根据35A SGB V的效益评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Geburtshilfe und Frauenheilkunde》 |2019年第6期|共6页
作者
Scharl Anton J.; Beckmann Matthias W.;
展开▼
作者单位

DGGG eV Berlin Germany;

DGGG eV Berlin Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献

1. Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V [J] . Scharl Anton J., Beckmann Matthias W. Geburtshilfe und Frauenheilkunde . 2019,第6期

机译：柏林，25.04.2019第277第277届妇科肿瘤工作组委员会委员会的陈述（前）e。 V.在德国妇科和妇产科社会中。 V.关于Palbociclib（乳腺癌） - 根据35A SGB V的效益评估
2. Berlin, 30.10.2019 Statement of the German Society for Gynecology and Obstetrics (DGGG) e. V. in cooperation with the Association for Gynecological Oncology (AGO) e. V. on Olaparib (new field of application: breast cancer, locally advanced or metastasized) 2019-07-15-D-459-Evaluation of benefits and harms according to 35a SGB V [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：柏林，30.10.2019德国妇科和妇产科协会声明（DGGG）e。五，与妇科肿瘤协会（前）的合作合作）。 V.关于奥拉帕里布（新申请新领域：乳腺癌，当地先进或转移）2019-07-15-D-459 - 根据35A SGB V的益处和危害评估
3. 280th Statement of the Committee Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. (DGGG) on the Pharmaceuticals Guidelines Ribociclib [J] . Scharl Anton J., Beckmann Matthias W. Geburtshilfe und Frauenheilkunde . 2019,第8期

机译：妇科肿瘤工作组委员会委员会第280届陈述（前）e。 V.在德国妇科和妇产科社会中。 V.（DGGG）关于药物指南riboCiclib
4. Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology Korean Society of Obstetrics and Gynecology and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement [O] . Miseon Kim, Tae-Wook Kong, Sunghoon Kim, 2019

机译：宫颈癌女性进行彻底子宫切除术的微创手术：韩国妇科肿瘤学会韩国妇产科学会韩国妇科内窥镜和微创手术学会立场声明
5. Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland [O] . A. M. Dueckelmann, D. Fink, P. Harter, 2018

机译：纠正：使用pipac（加压腹膜内气溶胶化疗）在妇科肿瘤学中：Arbeitsgemeinschaft gynaekologische onkologie（前）kommiscive ovar，前学习组，德国德国肿瘤学肿瘤学（noggo），以前奥地利奥地利瑞士

Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V

著录项

相似文献

相关主题

期刊订阅